Delivery Order SPE2DB20D3103-SPE2DB25FP4Q4
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of Twinrix vaccine in syringe format, with a ceiling value of $2,106.79. This is a firm fixed-price delivery order with an ultimate completion date of July 11, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical. The award carries no set-aside designation, indicating it was...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Twinrix vaccine in syringe format, with a contract ceiling value of $2,140.77. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The order is scheduled for completion by September 24, 2025, and represents a small-value transaction within AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Twinrix vaccine in syringe format, with a ceiling value of $1,932.13. This competitively awarded, firm fixed-price delivery order is classified as a child contract and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of August 26, 2025. The award carries no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Twinrix vaccine in syringe form, with a contract ceiling value of $4,948.52. This is a firm fixed-price delivery order with an ultimate completion date of September 11, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract was awarded through open competition with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Twinrix vaccine in syringe form, with a contract value of $2,184.12 and an ultimate completion date of July 31, 2025. This non-set-aside contract utilizes firm fixed price pricing and is classified as a delivery order under the company's existing indefinite delivery contract vehicle. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $1,610.43 to AmerisourceBergen Drug Corp for TWINRIX vaccine in syringe format. The award was issued on June 6, 2025, with an ultimate completion date of June 9, 2025. This non-set-aside, firm fixed-price delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a tactical procurement of immunization supplies to support federal medical supply chain...
- The Defense Logistics Agency awarded a delivery order valued at $2,162.19 to AmerisourceBergen Drug Corp for the supply of Twinrix vaccine in syringe format. This non-competitive delivery order, issued on August 22, 2025, with an ultimate completion date of August 25, 2025, represents a firm fixed-price transaction under AmerisourceBergen's existing contract vehicle with DLA. The work will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Twinrix vaccine in syringe format, valued at $1,455.70 with a completion date of September 10, 2025. This contract is a firm fixed price delivery order with no set-aside designation, performed at the contractor's Conshohocken, Pennsylvania location. The award represents a competitive procurement through open competition, consistent with AmerisourceBergen's established track record as a primary pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Twinrix vaccine syringes valued at $2,679.52. This non-competitive, firm fixed-price delivery order was executed on August 18, 2025, with an ultimate completion date of August 19, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single-line item procurement fulfilling federal medical supply requirements under the Defense Health...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of TWINRIX vaccine in syringe form, valued at $1,282.36, with an award date of June 12, 2025 and ultimate completion date of June 13, 2025. The contract employs firm fixed price pricing and was competitively awarded with no set-aside designation. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP4Q4Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of Twinrix vaccine in syringe form, with a ceiling value of $143,191.27. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement. The order is set to be completed by July 11, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement supporting federal medical supply chain requirements. This delivery order is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999, which runs through December 2026. That prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. The company's role as a major pharmaceutical distributor positions it to fulfill critical vaccine procurement needs across Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $143.2k | 7/10/25 |